Jaguar Health, Inc. (JAGX) is a publicly traded Healthcare sector company. As of October 21, 2026, JAGX trades at $2.39 with a market cap of $5.49M and a P/E ratio of -0.12. JAGX moved -5.89% today. Year to date, JAGX is -99.50%; over the trailing twelve months it is -99.77%. Its 52-week range spans $2.35 to $9,081.19. Rallies surfaces JAGX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
JAGX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. JAGX recently traded at $2.39. Market cap is $5.49M. P/E ratio is -0.12. Revenue is $27.82M.
| Metric | Value |
|---|---|
| Price | $2.39 |
| Market Cap | $5.49M |
| P/E Ratio | -0.12 |
| EPS | $-41.75 |
| Dividend Yield | 0.00% |
| 52-Week High | $9,081.19 |
| 52-Week Low | $2.35 |
| Volume | 185.12K |
| Avg Volume | 0 |
| Revenue (TTM) | $27.82M |
| Net Income | $-36.92M |
| Gross Margin | 82.31% |
JAGX analyst coverage data. Average price target: $0.00.